In nonsmall cell lung carcinoma, LINC01133 suppresses the transcription of KLF2, P21, and E‐cadherin by binding to EZH2 and LSD1, resulting in increased cancer cell growth and invasion.33 This evidence concerns the gene EZH2 and cancer.